Sarcopenia Intervention for Breast Cancer Patients

Sarcopenia Intervention to Gain Muscle and Advance Cancer Treatment in Breast Cancer Patients during Neoadjuvant Chemotherapy: The SIGMA trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0008961

Enrollment

Registered

2023-11-16

Start date

2024-05-14

Completion date

Unknown

Last updated

2025-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : The intervention has been developed in keeping with the guidelines of the American College of Sports Medicine and through collaborations with exercise experts and oncologists. Patients wi

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (1) Woman 20 years of age or older at diagnosis (2) Verified diagnosis of breast cancer (3) Scheduled for neoadjuvant chemotherapy (4) Willing to sign a form indicating informed consent and desire to participate

Exclusion criteria

Exclusion criteria: (1) Diagnosis of recurrent or metastatic breast cancer (2) 70 years of age or older at diagnosis (3) Have physical conditions that would make it difficult to perform the exercise program

Design outcomes

Primary

Measure	Time frame
sarcopenia	—

Secondary

Measure	Time frame
treatment-related adverse effects;cancer-related symptoms;quality of life	—

Countries

Korea, Republic of

Contacts

Public ContactMinjae Kang

Yonsei University

lejoo96@naver.com+82-2-2228-3363

Outcome results